RICEBRAN TECHNOLOGIES (RIBT) Fundamental Analysis & Valuation
NASDAQ:RIBT • US7628313030
Current stock price
0.35 USD
-0.01 (-1.69%)
At close:
0.3675 USD
+0.02 (+5%)
After Hours:
This RIBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. RIBT Profitability Analysis
1.1 Basic Checks
- RIBT had negative earnings in the past year.
- In the past year RIBT has reported a negative cash flow from operations.
1.2 Ratios
- RIBT has a Return On Assets of -141.05%. This is amonst the worse of the industry: RIBT underperforms 95.70% of its industry peers.
- Looking at the Return On Equity, with a value of -1786.67%, RIBT is doing worse than 94.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -141.05% | ||
| ROE | -1786.67% | ||
| ROIC | N/A |
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RIBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. RIBT Health Analysis
2.1 Basic Checks
- RIBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, RIBT has more shares outstanding
- Compared to 1 year ago, RIBT has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -39.85, we must say that RIBT is in the distress zone and has some risk of bankruptcy.
- RIBT has a worse Altman-Z score (-39.85) than 97.85% of its industry peers.
- A Debt/Equity ratio of 3.78 is on the high side and indicates that RIBT has dependencies on debt financing.
- RIBT has a worse Debt to Equity ratio (3.78) than 93.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.78 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -39.85 |
ROIC/WACCN/A
WACC7.79%
2.3 Liquidity
- A Current Ratio of 0.51 indicates that RIBT may have some problems paying its short term obligations.
- RIBT's Current ratio of 0.51 is on the low side compared to the rest of the industry. RIBT is outperformed by 94.62% of its industry peers.
- A Quick Ratio of 0.45 indicates that RIBT may have some problems paying its short term obligations.
- The Quick ratio of RIBT (0.45) is worse than 84.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.45 |
3. RIBT Growth Analysis
3.1 Past
- RIBT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.77%.
- The Revenue has grown by 19.84% in the past year. This is quite good.
- Measured over the past years, RIBT shows a very strong growth in Revenue. The Revenue has been growing by 25.52% on average per year.
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. RIBT Valuation Analysis
4.1 Price/Earnings Ratio
- RIBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. RIBT Dividend Analysis
5.1 Amount
- No dividends for RIBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RIBT Fundamentals: All Metrics, Ratios and Statistics
0.35
-0.01 (-1.69%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Industry Strength23.6
Industry Growth11.18
Earnings (Last)11-09 2023-11-09/amc
Earnings (Next)03-14 2024-03-14/amc
Inst Owners0.04%
Inst Owner Change0%
Ins Owners96.78%
Ins Owner Change0%
Market Cap2.31M
Revenue(TTM)32.98M
Net Income(TTM)-16.08M
Analysts43.33
Price Target4.59 (1211.43%)
Short Float %0%
Short Ratio0
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.07 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.57 | ||
| P/tB | 3.86 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS4.99
BVpS0.14
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -141.05% | ||
| ROE | -1786.67% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.78 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 27.88% | ||
| Cap/Sales | 1.39% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.45 | ||
| Altman-Z | -39.85 |
F-Score3
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)41.77%
Cap/Depr(5y)153.21%
Cap/Sales(3y)3.49%
Cap/Sales(5y)10.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.33%
OCF growth 3YN/A
OCF growth 5YN/A
RICEBRAN TECHNOLOGIES / RIBT Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for RICEBRAN TECHNOLOGIES?
ChartMill assigns a fundamental rating of 1 / 10 to RIBT.
Can you provide the valuation status for RICEBRAN TECHNOLOGIES?
ChartMill assigns a valuation rating of 0 / 10 to RICEBRAN TECHNOLOGIES (RIBT). This can be considered as Overvalued.
What is the profitability of RIBT stock?
RICEBRAN TECHNOLOGIES (RIBT) has a profitability rating of 0 / 10.
Can you provide the financial health for RIBT stock?
The financial health rating of RICEBRAN TECHNOLOGIES (RIBT) is 0 / 10.